Price Alert

Twist Bioscience Corporat... (TWST)

NASDAQ: TWST · Real-Time Price · USD

28.84

0.19 (0.66%)

At close: Aug 14, 2025, 3:59 PM

28.84

0.00%

Pre-market: Aug 15, 2025, 08:59 AM EDT

Twist Bioscience Statistics

Share Statistics

Twist Bioscience has 60.36M shares outstanding. The number of shares has increased by 2.27% in one year.

Shares Outstanding	60.36M
Shares Change (YoY)	2.27%
Shares Change (QoQ)	0.44%
Owned by Institutions (%)	99.99%
Shares Floating	57.31M
Failed to Deliver (FTD) Shares	386
FTD / Avg. Volume	0.03%

Short Selling Information

The latest short interest is 10.75M, so 17.93% of the outstanding shares have been sold short.

Short Interest	10.75M
Short % of Shares Out	17.93%
Short % of Float	20.26%
Short Ratio (days to cover)	11.95

Valuation Ratios

The PE ratio is -12.56 and the forward PE ratio is -19.15. Twist Bioscience's PEG ratio is 0.

PE Ratio	-12.56
Forward PE	-19.15
PS Ratio	8.38
Forward PS	3.8
PB Ratio	5.55
P/FCF Ratio	-37.89
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Twist Bioscience.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.18.

Current Ratio	4.88
Quick Ratio	4.54
Debt / Equity	0.18
Debt / EBITDA	-0.48
Debt / FCF	-1.23
Interest Coverage	-7614.86

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$339.08K
Profits Per Employee	$-226.14K
Employee Count	923
Asset Turnover	0.51
Inventory Turnover	7.46

Taxes

Income Tax	560K
Effective Tax Rate	-0.27%

Stock Price Statistics

The stock price has increased by -35.31% in the last 52 weeks. The beta is 2.37, so Twist Bioscience's price volatility has been higher than the market average.

Beta	2.37
52-Week Price Change	-35.31%
50-Day Moving Average	34.16
200-Day Moving Average	40.44
Relative Strength Index (RSI)	25.39
Average Volume (20 Days)	1,216,990

Income Statement

In the last 12 months, Twist Bioscience had revenue of 312.97M and earned -208.73M in profits. Earnings per share was -3.6.

Revenue	312.97M
Gross Profit	133.35M
Operating Income	-220.83M
Net Income	-208.73M
EBITDA	-176.71M
EBIT	-208.14M
Earnings Per Share (EPS)	-3.6

Full Income Statement

Balance Sheet

The company has 226.32M in cash and 85.03M in debt, giving a net cash position of 141.29M.

Cash & Cash Equivalents	226.32M
Total Debt	85.03M
Net Cash	141.29M
Retained Earnings	-1.24B
Total Assets	643.61M
Working Capital	252.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -64.09M and capital expenditures -5.08M, giving a free cash flow of -69.17M.

Operating Cash Flow	-64.09M
Capital Expenditures	-5.08M
Free Cash Flow	-69.17M
FCF Per Share	-1.19

Full Cash Flow Statement

Margins

Gross margin is 42.61%, with operating and profit margins of -70.56% and -66.69%.

Gross Margin	42.61%
Operating Margin	-70.56%
Pretax Margin	-66.51%
Profit Margin	-66.69%
EBITDA Margin	-56.46%
EBIT Margin	-70.56%
FCF Margin	-22.1%

Dividends & Yields

TWST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for TWST is $50, which is 81% higher than the current price. The consensus rating is "Buy".

Price Target	$50
Price Target Difference	81%
Analyst Consensus	Buy
Analyst Count	9

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	3.14
Piotroski F-Score	3